Evidence map›Paper›PMID 34577028›Full record

ArticleMolecules (Basel, Switzerland)2021

Design, Synthesis, and In Vivo and In Silico Evaluation of Coumarin Derivatives with Potential Antidepressant Effects.

Xuekun Wang, Hao Zhou, Xinyu Wang, Kang Lei, Shiben Wang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Coumarin benzamide scaffold as potential 5-HTJournal of molecular modeling · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xuekun WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252059, China.
Hao ZhouSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252059, China.
Xinyu WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252059, China.
Kang LeiSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252059, China.
Shiben WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252059, China.ORCID 0000-0002-8435-8135
Liaocheng University · CN

Funding

Major Project of Research and Development of Shandong Province 2019GSF108226National Natural Science Foundation of China 81803360Research Foundation of Liaocheng University 318012010Shandong Provincial Administration of Traditional Chinese Medicine 2017-525
6 · The paper itself

Abstract

In this study, a series of coumarin derivatives were designed and synthesized, their structures were characterized using nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS) testing methods. In the pharmacological experiment, two behavior-monitoring methods, the forced swim test (FST) and the tail suspension test (TST), were used to determine the antidepressant activity of coumarin derivatives. Compounds that showed potential activity were analyzed for their effects on 5-hydroxytryptamine (5-HT) levels in the brains of mice. Molecular docking experiments to simulate the possible interaction of these compounds with the 5-HT

Indexed as

Antidepressive AgentsCoumarinsMolecular Docking SimulationReceptor, Serotonin, 5-HT1AAnimalsBehavior, AnimalBrainComputer SimulationDrug DesignMaleMiceMolecular StructureSerotoninStructure-Activity RelationshipAntidepressive AgentscoumarinCoumarinsReceptor, Serotonin, 5-HT1ASerotonin5-HTantidepressantcoumarinFSTmolecular docking studiessynthesis

Identifiers

PMID34577028
PMCPMC8467986
OpenAlexW3199916165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.